MedTrace Logo

Hookworm Immune Regulation Project

NCT02262403 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-21

No results posted yet for this study

Summary

The main objective of this study is to characterize the regulatory immune response induced by hookworm in an infected Vietnamese rural population from the periphery of HCM, evolution after infection treatment and during potential naturally reinfection.

Conditions

  • Hookworm Infection

Interventions

OTHER

Blood and feces sampling

Blood and feces samples will be examined after 14 days, 28 days, 3 months and 16 months. This will require blood and feces sampling. The study is therefore defined as 'interventional' rather than 'observational' as it includes acts outside the standard of care.

Sponsors & Collaborators

  • Université Libre de Bruxelles

    collaborator OTHER

  • Brugmann University Hospital

    lead OTHER

Principal Investigators

  • Virginie Doyen, MD · CHU Brugmann - ULB

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262403 on ClinicalTrials.gov